Business Context and Reporting Period
Company: Actuate Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 21, 2025
Reporting Period: Single event date (November 21, 2025)
Business Overview: The registrant is an emerging growth company incorporated in Delaware, focused on therapeutic technologies. The company is listed on The Nasdaq Stock Market LLC under the symbol "ACTU".
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a disclosure of communication channels rather than a financial report.
Material Changes
No material financial or operational changes are reported in this filing. The document serves to inform investors of the official channels used to disseminate material information.
Guidance, Outlook, and Management Commentary
Disclosure Channels: Management directs investors to the following sources for material information regarding clinical and corporate developments:
- Company Website: https://actuatetherapeutics.com
- Investor Relations Page: https://actuatetherapeutics.com/investors
- Social Media: X (@ActuateThera), LinkedIn, and Facebook
Key Facts for Investor Verification
- Verify the company's status as an emerging growth company.
- Confirm the official trading symbol (ACTU) and exchange (Nasdaq).
- Monitor the listed website and social media accounts for future material announcements.
- Note that this filing contains no financial data; refer to periodic reports (10-K/10-Q) for financial metrics.